Dupixent drives a larger share of Sanofi's revenue, with atopic dermatitis, asthma, and CRSwNP as core indications. Learn ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

Eupraxia Pharmaceuticals Inc. (EPRX) garnered retail attention on Tuesday after the biotech company reported positive data ...

For the first time, Eupraxia is reporting 24-week data on symptom response from the highest dose cohort in the open label, Phase 1b/2a portion of ...

New research shows PPIs can limit fibrosis in eosinophilic oesophagitis, offering potential disease-modifying effects. Learn more about PPI therapy.

Raffle at Upcoming Islanders Game Will Support Eosinophilic Disease Research ATLANTA, GA, UNITED STATES, March 6, ...

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments. In this video, Brian Schroer, MD, ...

Background: Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease of the esophagus that affects both children and adults. Objective: The purpose of this article is to ...

Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic esophagitis (EoE), a chronic allergic inflammatory disease of the esophagus.

For people with eosinophilic esophagitis (EoE), a chronic immunologic disease, eating and diet arent always a piece of cake. In response to an allergen usually one or more food groups the lining of ...

Patients with eosinophilic esophagitis (EoE) often describe the condition as painful, disruptive and frightening. The rare chronic disease causes inflammation of the esophagus, leading to abdominal ...